Loading...
•
Jun 30, 2024
Select Medical Q2 2024 Earnings Report
Select Medical's financial performance increased, with revenue and net income rising compared to the same quarter last year.
Key Takeaways
Select Medical Holdings Corporation reported a 5.1% increase in revenue to $1,759.7 million for the second quarter ended June 30, 2024, compared to $1,674.5 million for the same quarter, prior year. Net income increased 3.2% to $94.8 million, and earnings per share were $0.60.
Revenue increased by 5.1% to $1,759.7 million compared to the same quarter last year.
Net income rose by 3.2% to $94.8 million compared to the same quarter last year.
Earnings per share (EPS) was $0.60, compared to $0.61 for the same quarter last year.
Adjusted EBITDA increased by 3.1% to $226.3 million compared to the same quarter last year.
Select Medical
Select Medical
Select Medical Revenue by Segment
Revenue by Segment
Critical Illness Recovery Hospital Revenue
CapyFin.comRehabilitation Hospital Revenue
CapyFin.comOutpatient Rehabilitation Revenue
CapyFin.com Forward Guidance
Select Medical reaffirms its 2024 business outlook, expecting revenue in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA in the range of $845 million to $885 million, fully diluted earnings per share in the range of $1.95 to $2.19, and adjusted earnings per share in the range of $1.96 to $2.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income